Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Tumor vaccines.

F K Stevenson1

  • 1Tenovus Laboratory, Southampton General Hospital, United Kingdom.

FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
|June 1, 1991
PubMed
Summary

Harnessing the immune system for cancer vaccination is a long-term goal. Advances in molecular biology and immunology are making anti-tumor immune responses a tangible possibility for treating certain human cancers.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Early stages in the ontogeny of small B-cell lymphomas: genetics and microenvironment.

Journal of internal medicine·2017
Same author

IL-10 production by CLL cells is enhanced in the anergic IGHV mutated subset and associates with reduced DNA methylation of the IL10 locus.

Leukemia·2016
Same author

Phenotypic heterogeneity in IGHV-mutated CLL patients has prognostic impact and identifies a subset with increased sensitivity to BTK and PI3Kδ inhibition.

Leukemia·2014
Same author

Idiotypes and diseases.

Immunology today·2014
Same author

Chronic lymphocytic leukaemia and normal B lymphopoiesis.

Immunology today·2014
Same author

DNA fusion vaccines against B-cell tumors.

Methods in molecular medicine·2011

Area of Science:

  • Immunology
  • Oncology
  • Molecular Biology

Background:

  • Cancer vaccination has been a long-standing objective in immunology.
  • Replacing traditional therapies like chemotherapy with sustained anti-tumor immune responses is ideal.
  • Progress has been hindered by limited understanding of viral roles in human cancer and tumor-associated antigens.

Purpose of the Study:

  • To explore the potential of cancer vaccination as a prophylactic or therapeutic strategy.
  • To investigate methods for enhancing the host's intrinsic ability to control tumor growth.
  • To leverage advancements in molecular biology and monoclonal antibody technology for cancer treatment.

Main Methods:

  • Utilizing molecular biology techniques and monoclonal antibody reagents.
  • Stimulating immune cells in vivo with biological modifiers.
  • Expanding immune cells in vitro for reinfusion into the host.

Main Results:

  • Recent developments indicate that cancer vaccination is becoming a realistic option for specific human cancers.
  • The host's immune system possesses an intrinsic capacity to control tumor growth, evidenced by tumor dormancy and growth rate fluctuations.
  • Research is actively exploring ways to enhance this natural immune control.

Conclusions:

  • Cancer vaccination is emerging as a viable therapeutic avenue for certain cancers.
  • Understanding tumor-associated antigens and viral roles is crucial for advancing anti-tumor immunity.
  • Harnessing and enhancing the host immune system offers a promising, albeit optimistic, approach to cancer treatment and understanding tumor biology.

Related Experiment Videos